Artio closes $28M as it scales to save lives; latest funding brings Prairie Village startup’s investments to $74M
June 16, 2022 | Startland News Staff
Another hefty funding round for Artio Medical is expected to launch the startup’s commercial sales team in the U.S. and continue development of its best-in-class product pipeline, said founder Nicholas Franano.
Artio, a medical device company developing innovative products for the peripheral vascular, neurovascular, and cardiology markets, on Thursday announced the closing of $28 million in oversubscribed Series A2 and Series A3 financing, bringing the total amount raised to date to $74 million.
Funds will be used to support U.S. commercialization efforts for the recently cleared Solus Gold Embolization Device and to accelerate the development of Artio’s broad portfolio of products, including expanding the company’s engineering and manufacturing capabilities, Franano said in a press release.
Click here to read more about Artio’s $12 million funding infusion in 2021.
“We would like to thank our existing investors for their continued strong support and also welcome a new group of investors to Artio,” said Joseph McConnell, vice president of finance and business operations at Artio.
“We have the opportunity to do something really special here, to bring a new generation of medical devices to market with the potential to save lives, reduce disability, and improve the quality of life for millions of people,” McConnell continued. “This new capital will help Artio expand our team and scale our operations to deliver on that mission.”
Artio is currently developing ten products for the peripheral vascular market, including the Solus Gold and Solus Flex Embolization Devices for peripheral vessel occlusion and the Amplifi Vein Dilation System which is designed to prepare hemodialysis patients for successful arteriovenous fistula vascular access site creation.
Artio is also currently developing four products for the neurovascular market, including the Endura Embolization System comprising a detachable balloon and coils for the treatment of saccular brain aneurysms.
Click here to learn more about Artio’s portfolio of products.
2022 Startups to Watch
stats here
Related Posts on Startland News
If you build it, they will come: KC leaders pitch downtown baseball to expats eying a return to home plate
Downtown baseball remains a winning prospect for Kansas City — and the Royals — civic and business leaders told a crowd of former residents who are considering a move back to KC, encouraging them to imagine a homecoming of big league proportions. “I think everyone agrees that Major League Baseball is a downtown sport,” Jon Stephens,…
Historic Troost space getting restocked; long-vacant Safeway next on Screenland’s grocery list
A one-story, long-empty, red brick building on Troost is now on the National Register of Historic Places — and set for new uses that reflect the modern-first vision behind its original construction. Redevelopers from Screenland Real Estate Services said the space at 3740 Troost Ave. was one of the first — if not the first…
This beloved family chicken chain is dropping its first new location in decades; Go for its G-Sauce in 2025
Kansas City’s longtime favorite Go Chicken Go is expanding to the Northland — its first new location in nearly 25 years. The hometown staple — a family-owned, third generation business based in Overland Park — is taking over the former Taco Bueno freestanding building at 380 N.E. Vivion Road, for an early 2025 opening. The new…
BLK + BRWN owner calls on funders to co-author bookstore’s story of activism for silenced narratives
A recently launched crowdfunding campaign to help BLK + BRWN make rent could mean the difference between access and censorship for the community served by the indie bookstore, said Cori Smith. “This is my flavor of activism,” Smith said of BLK + BRWN, the 39th Street business she describes as both a passion project and…